Chemoradiation combination could preserve larynx in patients with laryngeal and hypolaryngeal cancer

Researchers assessed the rates of laryngeal preservation and laryngectomy-free survival in patients with laryngeal or hypopharyngeal cancer who received the monoclonal antibody cetuximab and radiation therapy (CRT) or radiation therapy alone.
Oncology Nurse Advisor